ECM
SBBP

Element Capital Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Element Capital Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-51,372
Closed -$249K – 983
2018
Q3 		$249K Sell
51,372
-120,749
-70% -$618K 0.01% 669
2018
Q2 		$1.03M Buy
+172,121
New +$1.26M 0.03% 259

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Element Capital Management's SBBP Position: Q4 2018 in Review

Element Capital Management sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2018, closing a stake of 51,372 shares — an estimated $249K sold.

Element Capital Management first reported a position in SBBP in Q2 2018 and held it in 2 quarters. The position peaked at $1.03M in Q2 2018. 42 funds tracked by Wall St. Rank hold SBBP as of Q4 2018.

  • Element Capital Management reported no remaining Strongbridge Biopharma plc. position as of Q4 2018 after selling out during the quarter.
  • Element Capital Management sold 51,372 Strongbridge Biopharma plc. shares in Q4 2018, an estimated $249K.
  • Element Capital Management first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 2 quarters.
  • Element Capital Management's Strongbridge Biopharma plc. position peaked at $1.03M in Q2 2018.
  • 42 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2018.

Based on Element Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.